Partner Content

Empowering clinical trials: The technological revolution in patient retention

Recent years have seen a promising trend: the application of technology to revolutionise patient engagement and retention strategies. From mobile…

PRPs: What is a Patient Recruitment Platform (and why do you need one)?

The rise of sophisticated software solutions in clinical trials is equipping sponsors and their CROs with the advanced tools necessary…

Quality versus quantity in T-cell production: Why it doesn’t have to be a trade-off

Unlocking the potential of T cells offers hope to a range of patients with serious diseases, such as cancer, and…

The key products you need to trust your host-cell protein analysis and other process related impurity results

Developing and commercialising gene therapies can be a costly process. Specialised manufacturing facilities are required, and custom medicines can only…

The importance of pediatric participation: Can mobile visits attract and keep more children in clinical trials?

Empirically valid information documenting the effects of new therapies in children is essential for the safe and successful treatment of…

The state of oligonucleotide therapeutic manufacturing: what biopharmaceutical players need to know

Research on antisense oligonucleotides (ASOs) began in the early 1980s, leading to rapid advances in RNA-based therapeutics over the past…

The growing uses of medicinal cannabis

Medicinal cannabis has been found to have significant benefits for patients with a variety of conditions. Improvements have been observed…

The state of the diagnostic industry: cautious optimism for the coming years

The COVID-19 pandemic revolutionized the role of diagnostic testing in healthcare. At-home and laboratory testing became comfortable—and accessible—for patients across…

Rheumatoid arthritis in 2024: Navigating the global clinical trial landscape

Predicted to affect 1% of the world’s population by 2050, global Rheumatoid Arthritis (RA) cases will experience a significant 80.2%…

Candidiasis: global clinical trials and emerging treatments

New treatments for candidiasis are of high significance as the common fungal infection can lead to immense discomfort for patients…